首页> 外国专利> Factor VII or VIIa polypeptide variants with N-glycosylation

Factor VII or VIIa polypeptide variants with N-glycosylation

机译:具有N-糖基化的因子VII或VIIa多肽变体

摘要

A factor VII or Factor VIIa polypeptide variant having an amino acid sequence comprising 3-15 amino acid modifications relative to human Factor VII or human Factor VIIa having the amino acid sequence shown in SEQ ID NO:2. The amino acid sequence of the variant comprises the amino acid substitutions P10Q and K32E and a sugar moiety is covalently attached to an introduced in vivo N-glycosylation site located outside the Gla domain and is introduced by at least one substitution selected from the group consisting of A51N, G58N, T106N, K109N, G124N, K143+N145T, A175T, I205T, V253N, T267N, T267N+S269T, S314N+K316S, S314N+K316T, R315N+V317S, R315N+V317T, K316N+G318S, K316N+G318T, G318N and D334N. Also described are nucleotide sequences encoding the factor VII or Factor VIIa polypeptide variants, expression vectors comprising the nucleotide sequences, host cells comprising the nucleotide sequences and use of the variants in a medicament for the treatment of a disease or disorder where clot formation is desirable.
机译:相对于具有SEQ ID NO:2所示氨基酸序列的人因子VII或人因子VIIa,具有具有3-15个氨基酸修饰的氨基酸序列的氨基酸序列的因子VII或因子VIIa多肽变体。变体的氨基酸序列包含氨基酸取代P10Q和K32E,并且糖部分共价连接至位于Gla结构域外部的引入的体内N-糖基化位点,并通过选自以下的至少一个取代引入: A51N,G58N,T106N,K109N,G124N,K143 + N145T,A175T,I205T,V253N,T267N,T267N + S269T,S314N + K316S,S314N + K316T,R315N + V317S,R315N + V317T,K316N + G318S,K316N + G G318N和D334N。还描述了编码因子VII或因子VIIa多肽变体的核苷酸序列,包含核苷酸序列的表达载体,包含核苷酸序列的宿主细胞以及所述变体在药物中的用途,所述药物用于治疗需要形成血块的疾病或病症。

著录项

  • 公开/公告号NZ536340A

    专利类型

  • 公开/公告日2006-09-29

    原文格式PDF

  • 申请/专利权人 MAXYGEN HOLDINGS LTD;

    申请/专利号NZ20030536340

  • 申请日2003-04-29

  • 分类号C12N9/64;C07K14/745;A61K38/36;A61P7/04;C12N5/10;C12N15/63;

  • 国家 NZ

  • 入库时间 2022-08-21 21:38:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号